{
    "Trade/Device Name(s)": [
        "Atellica IM Folate Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K172201",
    "Predicate Device Reference 510(k) Number(s)": [
        "K010050"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGN"
    ],
    "Summary Letter Date": "April 12, 2018",
    "Summary Letter Received Date": "March 1, 2018",
    "Submission Date": "February 28, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.1295"
    ],
    "Regulation Name(s)": [
        "Folic acid test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Folate",
        "Folic acid"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Red blood cells",
        "Whole blood",
        "RBC hemolysate"
    ],
    "Specimen Container(s)": [
        "K2 EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Atellica IM Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence",
        "Competitive immunoassay"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent",
        "Diluent",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for Atellica IM Folate Assay for quantitative determination of folate in serum and red blood cells using the Atellica IM Analyzer.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of folate in serum or red blood cells using the Atellica IM Analyzer to aid in the diagnosis and treatment of anemias.",
    "fda_folder": "Clinical Chemistry"
}